Despite Risks, Huge Vaccination Experiment Underway in China

Advertisement

BEGIN ARTICLE PREVIEW:

China National Biotec Group Co., a subsidiary of state-owned Sinopharm, has given two experimental vaccine candidates to hundreds of thousands of people under an emergency-use condition approved by Beijing in July, the company said this week. Separately, Chinese drugmaker Sinovac Biotech Ltd. said it has inoculated around 3,000 of its employees and their family members, including the firm’s chief executive, with its experimental coronavirus vaccine.
The three vaccine candidates are still undergoing Phase 3 clinical trials, which involve testing a vaccine’s safety and effectiveness on thousands of people.Liu Peicheng, a spokesman for Sinovac, which said it has injected 3,000 employees and their family members, said the company’s recent vaccinations were purely voluntary and that it had disclosed to recipients the potential risks of taking the vaccine before the completion of clinical trials.Trump wanted an approved vaccine before the election. If there is one, it will be in China

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE